Trial Comparing Different Medical Devices for Infragenual Dilatation
- Conditions
- Intermittent ClaudicationDiabetic Angiopathies
- Interventions
- Procedure: Infragenual dilatation with stentingProcedure: Infragenual dilatation with cutting balloonProcedure: Laser therapyProcedure: Infragenual dilatation
- Registration Number
- NCT00134277
- Lead Sponsor
- University Hospital, Ghent
- Brief Summary
This study is a comparison of different medical devices for infragenual dilatation.
- Detailed Description
Dilatation and recanalisation of the distal veins (infragenual popliteal artery, tibiofibular trunc, posterior tibial artery, anterior tibial artery) by classical balloon dilatation or cutting balloon with or without stenting or by endovascular laser. This intervention happens only once; the duration of the intervention depends on the procedure and the original injuries(30 - 120 minutes).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- Diabetes type I or II with diabetic angiopathy stage IIb to IV (Fontaine)
- Atherosclerotic patients with distal angiopathy stage IIb to IV (Fontaine)
- Acute ischemia
- Multisegmentaric damage above the knee
- Sepsis: acute respiratory distress syndrome (ARDS), C-reactive protein (CRP) > 30, white blood cell (WBC) > 25,000
- Acute myocardial infarction (AMI) during the last 14 days
- Operative contraindication
- Life expectancy < 2 years
- Blue toe syndrome (micro-embolisation)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Infragenual dilatation with stenting Infragenual dilatation with stenting - Infragenual dilatation with cutting balloon Infragenual dilatation with cutting balloon - Laser therapy Laser therapy - Infragenual dilatation Infragenual dilatation -
- Primary Outcome Measures
Name Time Method Primary patency after 6 months After 6 months
- Secondary Outcome Measures
Name Time Method Proving the superiority or non-superiority of one treatment procedure to another treatment procedure After 6 months.
Trial Locations
- Locations (1)
University Hospital Ghent
🇧🇪Ghent, Belgium